5 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
GRFS or ZTS: Which Is the Better Value Stock Right Now? https://www.zacks.com/stock/news/2226324/grfs-or-zts-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2226324 Feb 14, 2024 - GRFS vs. ZTS: Which Stock Is the Better Value Option?
Company News for Feb 14, 2024 https://www.zacks.com/stock/news/2226118/company-news-for-feb-14-2024?cid=CS-ZC-FT-corporate_summary-2226118 Feb 14, 2024 - Companies in The News Are: ZTS,MAR,ECL,HAS
1 Magnificent S&P 500 Dividend Stock Down 23% to Buy Right Now https://www.fool.com/investing/2024/02/26/1-magnificent-sp-500-dividend-stock-down-23-to-buy/?source=iedfolrf0000001 Feb 26, 2024 - Buoyed by megatrends in animal healthcare, this stock makes for an excellent holding in almost any portfolio.
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts https://www.zacks.com/stock/news/2259683/zoetis-zts-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2259683 Apr 22, 2024 - In the latest trading session, Zoetis (ZTS) closed at $145.54, marking a -0.66% move from the previous day.
BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release https://www.zacks.com/stock/news/2264204/biocryst-pharmaceuticals-bcrx-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2264204 Apr 29, 2024 - BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Pages: 1

Page 1